Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Marie‐Christine Bründer"'
Autor:
Helena Siegel, Annika Merz, Nikolai Gross, Marie-Christine Bründer, Daniel Böhringer, Thomas Reinhard, Philip Maier
Publikováno v:
BMC Ophthalmology, Vol 24, Iss 1, Pp 1-9 (2024)
Abstract Background Blepharitis is a chronic inflammatory condition of the eyelids that affects a large proportion of patients in eye care settings. First-line treatments provide only partial relief for many patients. The BlephEx™ device provides a
Externí odkaz:
https://doaj.org/article/eee6435873fc481f8c66a55bba31db13
Autor:
Thomas Wecker, Bastian Grundel, Milena Grundel, Marie-Christine Bründer, Simon Trick, Clemens Lange, Daniel Böhringer, Hansjürgen Agostini, Andreas Stahl
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-7 (2021)
Abstract Macular edema (ME) is the most frequent vision threatening consequence after retinal vein occlusion (RVO). In this study, we evaluate the effect of dexamethasone intravitreal implants (DII, Ozurdex) in a real-life cohort of 99 patients with
Externí odkaz:
https://doaj.org/article/a618870fd8174289bae2b33e07f100e2
Autor:
Martin Busch, Johanna M. Pfeil, Merlin Dähmcke, Tara Brauckmann, Rico Großjohann, Viola Chisci, Elisabeth Hunfeld, Sonja Eilts, Wael Omran, Ewa Morawiec‐Kisiel, Daniel Schulz, Sebastian Paul, Allam Tayar, Marie‐Christine Bründer, Bastian Grundel, Martin Küstner, Andreas Stahl
Publikováno v:
Acta Ophthalmologica. 100:903-910
Postapproval reports of intraocular inflammation (IOI) and occlusive retinal vasculitis following intravitreal brolucizumab are accumulating. A role of anti-drug antibodies (ADAs) to brolucizumab is under current scientific discussion. The purpose of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4fb779e7ad1ceda14eaf7eb15939d58c
https://doi.org/10.1111/aos.15124
https://doi.org/10.1111/aos.15124
Autor:
Sebastian Paul, Allam Tayar, Ewa Morawiec-Kisiel, Beathe Bohl, Rico Großjohann, Elisabeth Hunfeld, Martin Busch, Johanna M. Pfeil, Merlin Dähmcke, Tara Brauckmann, Sonja Eilts, Marie-Christine Bründer, Milena Grundel, Bastian Grundel, Frank Tost, Jana Kuhn, Jörg Reindel, Wolfgang Kerner, Andreas Stahl
Publikováno v:
Die Ophthalmologie. 119:705-713
Zusammenfassung Hintergrund Seit 2018 ist mit IDx-DR ein Verfahren auf dem Markt, welches den Grad der diabetischen Retinopathie (DR) mittels künstlicher Intelligenz (KI) bestimmt. Methoden Wir haben IDx-DR in die Sprechstunde an einer diabetologisc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8c753a29ad3ac64b5da7ba76cc660043
https://doi.org/10.1007/s00347-021-01556-5
https://doi.org/10.1007/s00347-021-01556-5
Publikováno v:
Neonatologie Scan. :293-306
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b32d0428431b20d59b5a5b5574439469
https://doi.org/10.1055/a-1002-4756
https://doi.org/10.1055/a-1002-4756
Autor:
Bastian Grundel, Thomas Ness, Daniel Böhringer, Thomas Reinhard, Marie-Christine Bründer, Thomas Haug, Milena Stech
Publikováno v:
Klinische Monatsblätter für Augenheilkunde. 237:980-984
Zusammenfassung Einführung Special Olympics Deutschland (SOD) ist die deutsche Organisation der weltweit größten Sportbewegung für Menschen mit geistiger und mehrfacher Behinderung: Viele Landesverbände von SOD bieten mittlerweile alle 4 Jahre S
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2ae1532f61893e1757a1000ab576cfe5
https://doi.org/10.1055/a-1141-3911
https://doi.org/10.1055/a-1141-3911
[Use of artificial intelligence in screening for diabetic retinopathy at a tertiary diabetes center]
Autor:
Sebastian, Paul, Allam, Tayar, Ewa, Morawiec-Kisiel, Beathe, Bohl, Rico, Großjohann, Elisabeth, Hunfeld, Martin, Busch, Johanna M, Pfeil, Merlin, Dähmcke, Tara, Brauckmann, Sonja, Eilts, Marie-Christine, Bründer, Milena, Grundel, Bastian, Grundel, Frank, Tost, Jana, Kuhn, Jörg, Reindel, Wolfgang, Kerner, Andreas, Stahl
Publikováno v:
Die OphthalmologieLiteratur. 119(7)
In 2018, IDx-DR was approved as a method to determine the degree of diabetic retinopathy (DR) using artificial intelligence (AI) by the FDA.We integrated IDx-DR into the consultation at a diabetology focus clinic and report the agreement between IDx-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::08adea6fb8e1065d78bd5227e990cd19
https://pubmed.ncbi.nlm.nih.gov/35080640
https://pubmed.ncbi.nlm.nih.gov/35080640
Autor:
Ann Hellström, Staffan Nilsson, Kristina Tornqvist, Pia Lundgren, Abbas Al-Hawasi, Kerstin Albertsson-Wikland, Chatarina Löfqvist, Agneta Wallin, Bradley A. Yoder, Helena Johansson, Eva Larsson, Gerd Holmström, Marie Christine Bründer, Lotta Gränse, Carolyn Wu, Andreas Stahl, Birgitta Sunnqvist, Lois E.H. Smith, M. Elizabeth Hartnett, Aldina Pivodic, Wolf A. Lagrèze, Anna-Lena Hård
Publikováno v:
The British journal of ophthalmology. 106(11)
Background/Aims Prematurely born infants undergo costly, stressful eye examinations to uncover the small fraction with retinopathy of prematurity (ROP) that needs treatment to prevent blindness. The aim was to develop a prediction tool (DIGIROP-Scree
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9f81d97dbe01c0f948d7aa8d1ed387ec
https://pubmed.ncbi.nlm.nih.gov/33980506
https://pubmed.ncbi.nlm.nih.gov/33980506
Autor:
Andreas, Stahl, Marie-Christine, Bründer, Wolf A, Lagrèze, Fanni E, Molnár, Teresa, Barth, Nicole, Eter, Rainer, Guthoff, Tim U, Krohne, Johanna M, Pfeil, Lois, Smith
Publikováno v:
Acta ophthalmologica. 100(1)
Purpose The primary endpoint results from the comparing alternative ranibizumab dosages for safety and efficacy in retinopathy of prematurity (CARE-ROP) core study identified ranibizumab as an effective treatment to control acute retinopathy of prema
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ccfadee79d9d2a90f2a5d27cf06abafd
https://pubmed.ncbi.nlm.nih.gov/33742551
https://pubmed.ncbi.nlm.nih.gov/33742551
Autor:
Thomas Wecker, Bastian Grundel, Milena Grundel, Marie-Christine Bründer, Simon Trick, Clemens Lange, Daniel Böhringer, Hansjürgen Agostini, Andreas Stahl
Publikováno v:
Scientific Reports
Scientific Reports, Vol 11, Iss 1, Pp 1-7 (2021)
Scientific Reports, Vol 11, Iss 1, Pp 1-7 (2021)
Macular edema (ME) is the most frequent vision threatening consequence after retinal vein occlusion (RVO). In this study, we evaluate the effect of dexamethasone intravitreal implants (DII, Ozurdex) in a real-life cohort of 99 patients with ME due to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::2d93a2ba0135e55e40679cfdb430f881
https://pubmed.ncbi.nlm.nih.gov/33859243
https://pubmed.ncbi.nlm.nih.gov/33859243